Loading...
Loading...
By Sofía Garduño - Wed, 12/10/2025 - 09:38
Pfizer and YaoPharma sign a global agreement to advance GLP-1 candidate YP05002 for weight management, expanding Pfizer’s cardiometabolic pipeline.
Featured content
Partnership Content
https://mexicobusiness.news/tag/obesity-drugs
More Health
By Anmol Motwani - Fri, 07/26/2024 - 11:43
GLP-1 obesity drugs impact food sales, with users buying 8% less, reports J.P. Morgan
